top
Search terms
Results 1 - 10 of 12 - ordered by :
Pages: 1 2
Ehjcvp

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, Henrik Renlund, Lars Wallentin, Stefan K. James, Tomas Jernberg

Date : 01/01/2016 Item size : 280123 bytes
Ehjcvp

Mechanistically, this separates the drug from conventional anti-anginal therapies, namely beta-adrenergic antagonists, calcium channel blockers, and nitrates. [...]a haemodynamically neutral ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Cian P. McCarthy, Kieran V. Mullins, David M. Kerins

Date : 01/10/2016 Item size : 282882 bytes
Ehjcvp

The WG contributes to most ESC guidelines with expertise on cardiovascular pharmacotherapy. [...]over the last 2 years the WG has beenor is stillinvolved in eight ESC guidelines. Gender differences ...

European Heart Journal - Cardiovascular Pharmacotherapy, CORRESPONDENCE, Keld Kjeldsen

Date : 01/01/2015 Item size : 98083 bytes
Ehjcvp

[...]our presence in MEDLINE will increase the visibility of, and interest for, the journal. [...]the editors and editorial board members feel very satisfied and confident for the future of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/10/2016 Item size : 112617 bytes
Ehjcvp

Given the burden of cardiovascular disease in patients with diabetes, the focus should shift towards cardiovascular outcome studies designed to evaluate efficacy (i.e. to determine the efficacy of a ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Faiez Zannad, Wendy Gattis Stough, Raymond J. Lipicky, Juan Tamargo, George L. Bakris, Jeffrey S. Borer, Maria de los Angeles Alonso ...

Date : 01/07/2016 Item size : 285307 bytes
Ehjcvp

Abstract Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, R. Kumar, D. M. Kerins, T. Walther

Date : 01/01/2016 Item size : 517106 bytes
Ehjcvp

There are already several scientific journals within clinical cardiology; however, this new journal will have a specified focus on clinical cardiovascular pharmacology. Despite this fast development ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/01/2015 Item size : 98592 bytes
Ehjcvp

Furthermore, even the truth changes since we perform new studies and since people challenge the truth When I was in Medical School one professor of Medicine told the class, Damn you if you treat ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/04/2015 Item size : 97793 bytes
Ehjcvp

Furthermore, we report advantages and disadvantages of respiratory drugs (β2 agonists, anti-cholinergics, and corticosteroids) administration in COPD patients with CVD. cardiovascular ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Gianluca Campo, Rita Pavasini, Simone Biscaglia, Marco Contoli, Claudio Ceconi

Date : 01/07/2015
Ehjcvp

Mechanistically, this separates the drug from conventional anti-anginal therapies, namely beta-adrenergic antagonists, calcium channel blockers, and nitrates. [...]a haemodynamically neutral ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Cian P. McCarthy, Kieran V. Mullins, David M. Kerins

Date : 09/12/2015